Is classical stereotactic radiotherapy the optimal partner for immunotherapy?
Oncology (Williston Park)
.
2015 May;29(5):340, 347, 387.
Author
Silvia C Formenti
PMID:
25979542
No abstract available
MeSH terms
Combined Modality Therapy
Humans
Immunotherapy*
Neoplasms / therapy*
Radiosurgery*